We also have now investigated global protein expression in the kidney of experimental animals, using a proteomic technique consisting of two-dimensional gel electrophoresis and matrix-assisted laser desorption ionization-time-of-flight (MALDI-TOF) mass spectrometry. In the present study, we report the sex differences in renal proteins increased or decreased by I/R treatment. It is known that female rats are resistant to ischemic acute renal failure (ARF), compared with male rats. To elucidate sex differences in ischemic ARF, we searched global protein expression in post-ischemic kidneys using proteomic techniques. Ischemic ARF was induced by 45-min ischemia followed by reperfusion. By proteomic analysis, many male-or female-dominant proteins were detected in sham-operated rat kidneys, and significantly increased or decreased proteins were found in post-ischemic kidneys 2 h after reperfusion, at which there were no significant deterioration in renal function of both sexes. We detected 86 proteins showing more than 1.5-fold significant alterations (pϽ0.01) in both sexes by ischemia/reperfusion (I/R) treatment. Among the altered proteins, we identified a significantly up-regulated protein in male rat kidneys, meprin a a, a subunit of meprin which had been reported to play a role in the pathophysiology of I/R-induced ARF. In addition, it is known that a potent meprin a a inhibitor, actinonin, can protect against I/R-induced renal injury when administered to male rats. We therefore compared the effect of actinonin on I/R-induced renal dysfunction between male and female rats. Renal function of both males and females showed significant deterioration when measured at 24 h after the reperfusion, although the degree of renal dysfunction was much less in females than in males. Pre-ischemic treatment with actinonin (30 mg/kg, i.v.) prevented the I/R-induced renal dysfunction in males but not in females. Our results provide information on differences in protein expression at an early phase after the reperfusion between male and female rats. Moreover, the present study suggests that up-regulation of meprin a a in the post-ischemic kidney is at least partly involved in aggravation of I/R-induced renal injury in male rats. The possibility that meprin a a is a key component of the sex difference in ischemic ARF, warrants further attention.
Ischemia/reperfusion (I/R) injury is a leading cause of acute renal failure (ARF) which is a frequent clinical syndrome with high morbidity and mortality. 1) Structural changes in post-ischemic kidneys are characterized by vasoconstriction or necrosis with desquamation of tubular epithelial cells into the tubular lumen. The molecular mechanisms underlying this renal injury are not fully understood, although it has been reported that several causal factors, such as reactive oxygen species, neutrophil infiltration, vasoactive peptides and ATP depletion, are contributive to the pathogenesis of I/R-induced ARF.
2) Sex hormones are also known to relate with the development and progression of ischemic insult. We showed that 17b-estradiol prevented I/R-induced renal damage in male rats. 3) Müller et al. 4) found that this female hormone resulted in a significantly better survival for I/R-treated male rats, but testosterone treatment had no impact on the survival in females. In contrast, Park et al. 5) reported that testosterone administration to female mice increased renal susceptibility to I/R-induced injury.
In addition to these effects of steroid hormones, it is known that sex differences exist in I/R-induced ARF. [4] [5] [6] [7] [8] There are consistent findings that females are more resistant to I/R-induced renal injury than males. A few factors were found to be associated with sex differences in I/R-induced ARF of rodent models: mRNA expression of endothelin-1, a causal factor for ischemic ARF, 9) is increased at an early phase following reperfusion in male rats, but not in female rats; 4) enzyme activity of Na ϩ , K ϩ -ATPase after I/R treatment is higher in female than in male rats 7) ; heat shock protein (Hsp) 72 exhibits the higher basal and postischemic levels in the kidney of female rats. 8) Investigation of sex differences at the molecular levels might therefore provide a new area for mechanistic study of ischemic ARF.
A number of data have been provided in kidney research using transcriptomic and proteomic techniques. The principles and characteristics of these techniques has been reviewd. 10, 11) Using DNA microarray technology, Yoshida et al. 12) identified changes in expression of 18 genes after I/R treatment of male rats, and Supavekin et al. 13) observed some pro-apoptotic or anti-apoptotic genes expression altered in I/R-treated kidneys of male mice, suggesting that apoptosis may represent an important mechanism for the early loss of tubular cells by I/R treatment. Such transcriptomic analyses provide us with parallel and quantitative expression profiles of thousands of mRNA, and are probably effective to find important factors in the development of renal diseases such as I/R-induced ARF. Proteomic analyses have also been used to examine changes in proteins specific to regions of kidney or associated with several renal diseases and toxicity.
Sprague-Dawley rats (10 weeks of age, Japan SLC, Inc., Shizuoka, Japan) weighing 280-320 g and 180-200 g, respectively, were used. The animals were housed in a lightcontrolled room with a 12-h light/dark cycle and were allowed ad libitum access to food and water. Experimental protocols and animal care methods in the experiments were approved by the Experimental Animal Committee at Osaka University of Pharmaceutical Sciences (Osaka, Japan). Two weeks before the study (at 8 weeks of age), the right kidney was removed through a small flank incision under pentobarbital anesthesia (50 mg/kg, i.p.). After a 2-week recovery period, the rats were anesthetized with pentobarbital (50 mg/kg, i.p.), and the left kidney was exposed through a small flank incision. The left renal artery and vein were occluded with a nontraumatic clamp for 45 min. At the end of the ischemic period, the clamp was released to allow reperfusion. In shamoperated control rats, the kidney was treated identically, except for the clamping. At various time points after the start of reperfusion, blood samples were drawn from the thoracic aorta under pentobarbital anesthesia (50 mg/kg, i.p.). The plasma was separated by centrifugation. These samples were used for measurement of renal function parameters. In separate experiments, we examined the effect of actinonin, an inhibitor of meprin a, on I/R-induced ARF: actinonin (30 mg/kg; Sigma Chemical Co., St. Louis, MO, U.S.A.) or vehicle (a mixture of 20% ethanol, 30% polyethylene glycol 400 and 50% saline) was administrated 5 min before the start of ischemia, in a volume of 1 ml/kg into the external jugular vein. Plasma samples were obtained from animals exposed to 45-min ischemia followed by 24 h reperfusion and from sham-operated rats, as described above.
Renal Functional Parameters Blood urea nitrogen (BUN) and plasma creatinine (Pcr) levels were determined using a commercial assay kit, the BUN-test-Wako and Creatinine-test-Wako (Wako Pure Chemicals Industries, Osaka, Japan), respectively.
Protein Preparation For proteomic analysis, kidneys were obtained from sham-operated (sham group, nϭ3) and I/R-treated rats (I/R group, nϭ3), and were frozen with liquid nitrogen and stored at Ϫ80°C until analyzed. The kidneys were disrupted in a homogenization buffer containing 30 mM Tris, 7 M urea, 2 M thiourea, 4% CHAPS, 20 mM DTT and a protease inhibitor cocktail (GE Healthcare Bio-Sciences, Buckinghamshire, U.K.), using Multi-Beads Shocker (Yasui Kikai Co., Osaka, Japan). These sample solutions were centrifuged at 7000ϫg for 30 min at 4°C. The obtained supernatant was withdrawn as the protein lysate. Protein concentration was determined according to the modified Lowry assay method.
17)
Protein Separation A 50 mg aliquot of protein was labeled with 400 pmol CyDye DIGE Fluor minimal dyes (Cy2, Cy3 and Cy5, GE Healthcare) according to manufacturer's instructions. To derive statistically valid data on differences between sham-operated male and female kidneys, or between sham-operated normal and I/R-induced injured kidneys within the same sex, equal amounts of each of protein lysates obtained from the 4 groups were mixed, labeled with Cy2 and designated as the pooled internal standard. Protein samples obtained from an individual kidney were labeled with Cy3 or Cy5. The Cy2-, Cy3-and Cy5-labeled proteins were mixed together, prior to the first-dimensional isoelectric focusing (IEF). The mixed samples were loaded on IPGphor strips (24 cm) at pH 3-10. IEF was performed on an Ettan IPGphor (GE Healthcare) with the following steps; increasing voltage 500 V for 1 h, 1000 V for 1 h, and held at 8000 V for 10.5 h. Strips after first-dimension separation were equilibrated for 15 min in a buffer solution (50 mM Tris-HCl, pH 8.8, 6 M urea, 30% glycerol, 2% SDS, and 0.002% bromophenol blue) containing 10 mg/ml dithiothreitol (DTT) followed by a second 15-min equilibration with the buffer containing 25 mg/ml iodoacetamide instead of DTT. The strips were loaded onto precast 12.5% SDS-PAGE gels (dimension; 26ϫ24ϫ0.1 cm 3 ), and second-dimension electrophoresis was performed at a constant power of 30 W/gel using Ettan Dalt system (GE Healthcare) until the bromophenol blue dye front migrated off the bottom of the gel. Gel images for analysis were obtained using a Typhoon 9400 Variable Mode Imager (GE Healthcare). The resulting gel images were analyzed using a DeCyder Differential Analysis Software (GE Healthcare). All Cy2 images were assigned as the internal standard. The gel with a great number of spots was automatically assigned as the master gel, and the other gels were matched to the master gel. For statistical analysis, protein abundance of each spot was normalized with the internal standard, as the Cy3-to-Cy2 or Cy5-to-Cy2. Student's t test was performed for every matched spot set, comparing the average and standard deviation of protein abundance for a given spot between male and female sham groups. By the same statistical analysis, gel images were compared between sham and I/R groups within the same sex. Differences were considered significant at pϽ0.01.
Protein Identification After a 500 mg aliquot of proteins was separated by two-dimensional gel electrophoresis as described above, gels were stained with Deep Purple Total Protein Stain (GE Healthcare) according to manufacturer's instructions. We selected gel spots showing a more than 1.5-fold significant increase or decrease in protein abundance at pϽ0.01, between male and female sham groups, or between sham and I/R groups within the sexes. The selected protein spots were cut out by the automated Ettan Spot picker (GE Healthcare). For in-gel digestion, the excised gel spots were incubated in trypsin solution at 37°C overnight. The digested peptides were extracted with 50% acetonitrile/5% trifluoroacetic acid (TFA) and dried with vacuum for 3 h, followed by reconstruction with 0.1% TFA. After each sample was desalted using a ZipTip (Millipore Corp., Billerica, MA, U.S.A.), peptides were eluted directly onto the MALDI sample stage with a-cyano-4-hydroxycinnamic acid in 50% acetonitrile/0.1% TFA. The samples were analyzed by a Voyager time-of-flight mass spectrometer (Applied Biosystems Japan Ltd., Tokyo, Japan). The MALDI-TOF mass spectra were used to identify proteins by peptide mass fingerprinting in MASCOT search engine (http://www.matrixscience.com/) based on the National Center for Biotechnology Information non-redundant database.
Statistical Analysis Values were expressed as meanϮ S.E.M. Relevant data were processed by InStat (Graph-PAD Software for Science, San Diego, CA, U.S.A.), except for proteomic analysis. Statistical analysis for renal functional studies was performed using Student's unpaired t test for two-group comparison or one-way analysis of variance followed by Dunnett's or Bonferroni's multiple comparison tests. For all comparisons, differences were considered significant at pϽ0.05. Figure 1 shows time course profiles of BUN and Pcr as renal functional parameters in ARF rats subjected to 45-min ischemia. In both male and female rats, there were no significant increases in BUN and Pcr levels 2 h after the reperfusion; and thereafter, these parameters increased gradually after the reperfusion, and significantly elevated 24 h after the reperfusion. Furthermore, female rats showed statistically significant lower values of BUN and Pcr levels 6 and 24 h after the reperfusion, compared with male rats, indicating the sex difference in I/Rinduced renal dysfunction. [4] [5] [6] [7] [8] Based on these time course profiles, we compared changes of protein expression in male and female kidneys 2 h after reperfusion, in order to explore possible candidates as a causal factor of the above sex differencese.
RESULTS

Time Course of Renal Functional Parameters after the I/R in Male and Female Rats
Protein Expression in Sham-or I/R-Treated Male and Female Rat Kidneys
Renal proteins from individual animals in sham-or I/R-treated male and female groups were separated by two-dimensional gel electrophoresis. Representative two-dimensional gels obtained from 4 groups are shown in Fig. 2 . A total of 1317 protein spots was matched by computer comparison of gel images.
We first compared differences in protein expression between sham-operated male and female rat kidneys. Of visualized protein spots, 24 and 20 spots were significantly increased and decreased in females compared with males, respectively. Of these 44 spots, 30 spots (Figs. 2A, B) representing 18 proteins were able to identify using MALDI-TOF Each column and bar represents the meanϮS.E.M. Statistical analysis was performed using Student's unpaired t test for two-group comparison and using one-way analysis of variance followed by Dunnnett's tests for multiple comparisons. * * pϽ0.01, compared with sham-operated male rats. # pϽ0.05, ## pϽ0.01, compared with sham-operated female rats. † pϽ0.05, † † pϽ0.01, compared with male rats at the same time point. Proteins labeled with CyDye DIGE Fluor dye were separated by 2-dimensional gel electrophoresis on the basis of differential isoelectric points (x-axis) and molecular weights (yaxis). The numbers correspond to the spot numbers listed in Tables 1 and 2 . Table 1 ).
We next compared differences in renal protein expression between sham and I/R groups within the same sex. As shown in Fig. 3 , I/R treatment induced significant increases or decreases in protein abundant of total 86 spots. Of these spots, 60 and 4 spots were significantly up-regulated in males and females, respectively. On the other hand, 10 spots were significantly down-regulated by I/R treatment and were classified into either male-(7 spots) or female-(3 spots) specifically decreased proteins. Of proteins which were significantly altered in I/R-treated male rat kidneys, 19 up-regulated (Fig. 2C, spot No. 31-49) and 4 down-regulated spots (Fig. 2C, spot No. 50-53) were able to be identified and shown in Table 2 . In addition, 2 protein spots which were significantly decreased in I/R-treated female rat kidneys (Fig.  2D, spot No. 54, 55) were able to be identified (Table 2) . We furthermore identified several protein constituents of blood including albumin and fibrinogen in I/R-treated kidneys (indicated with asterisks in Table 2 ). Almost of these proteins were significantly up-regulated in males compared with females, except for zero b-globin.
Effect of Actinonin, a Meprin a a Inhibitor, on I/RInduced ARF in Male and Female Rats Among proteins identified by our proteomic analysis, meprin a is of interest to us, since meprin having meprin a subunit has been reported to play a role in the pathophysiology of I/R-induced ARF. 18) In addition, studies with male rats have demonstrated that actinonin, a potent inhibitor of meprin a, can protect against I/R-induced renal injury as determined by BUN and Pcr. 19 ) Therefore, we next compared the effect of actinonin on I/R-induced renal dysfunction in both male and female rats (Table 3) . Renal function of both males and females subjected to a 45-min ischemia showed significant deterioration when measured at 24 h after reperfusion: as compared with respective sham-operated rats, I/R-treated rats showed significant increases in BUN and Pcr, although the degree of renal dysfunction was much less in females than in males. Preischemic treatment with actinonin (30 mg/kg, i.v.) prevented the I/R-induced renal dysfunction in males, but no preventive effects were observed in females.
DISCUSSION
In the present study, we first compared differences in protein expression profiles between sham-operated male and female kidneys. Comparison of two-dimensional gel electrophoresis of renal proteins from males and females revealed 44 protein spots that displayed a statistically significant sex-dependence. Using MALDI-TOF mass spectrometer, 18 proteins were able to identify in this study. Among the identified proteins (Table 1) , sex-dependent expression of ornithine aminotransferase, carbonic anhydrase 2 or regucalcin was in accordance with that obtained by other immunochemical or proteomic analysis: expression of ornithine aminotransferase is higher in females than males when analyzed by Western blotting of kidney homogenates from mice 20) ; contents of carbonic anhydrase 2 are higher in females than males when measured by radioimmunoassay of rat liver extracts 21) ; and regucalcin has been shown to be lower in females than males by proteomic analysis of nuclear proteins from the rat liver. 22) Thus, our proteomic analysis used in the present study is considered to be sufficiently applicable for clarifying difference in the expression of renal proteins between I/R-treated male and female rats.
By the proteomic analysis, we detected 86 proteins showing more than 1.5-fold significant alterations in the kidney of both sexes 2 h after reperfusion, and these proteins showed quantitative differences between males (60 up-regulated and 7 down-regulated proteins) and females (4 up-regulated and 3 down-regulated proteins), except for 12 up-regulated proteins without sex dimorphism. Of significantly altered proteins, several proteins were identified as blood constituents such as albumin and fibrinogen (Table 2) . Interestingly, almost of these proteins, which could not be detected in the kidney obtained from sham-operated rats, were male-dominant in I/R-treated rats. Müller et al. 4) has reported that the post-ischemic recovery of renal blood flow is delayed in male, compared with female rats, and that renal vascular resistance increases in males, whereas it remains unchanged in females as compared to baseline values, thereby suggesting that the difference in renal blood flow results from renal vasoconstriction pronounced in males. Based on these findings, it is reasonable to consider that the blood constituents increased in I/R-treated male rat kidneys are probably derived from residual blood in the kidney where blood accumulation is caused by pronounced renal vasoconstriction.
Except for blood constituents, we identified 25 spots representing 22 proteins, which showed significantly quantitative variations in I/R-treated rats compared with sham-operated rats (Table 2) . Among these proteins, we noticed ezrin (spot No. 50 in Table 2 ) and meprin a (spot No. 31 in Table 2 ) that are associated with injury of proximal tubular cells. The former was significantly down-regulated 2 h after reperfusion in the I/R-treated male rat kidney. Ezrin is known to be a linker proteins between the plasma membrane and the actin cytoskeleton at the apical side of renal proximal tubular cells and dissociated from the renal microvillar actin by energy depletion. 23, 24) Thus, the significant down-regulation of ezrin protein in the post-ischemic kidney of male rats might cause more severe renal tissue disruption.
In contrast to the case of ezrin, meprin a was significantly up-regulated 2 h after the reperfusion in the I/R-treated male rat kidney. Meprin a is a subunit of meprin which is a metalloendopeptidase localized on the brush-border membrane of renal proximal tubular cells. 25) The meprin a subunit has no transmembrane domain because it is proteolytically cleaved during biosynthesis and therefore, this subunit exists at the membrane only when it associates with the other membranebound subunit meprin b. 26) Walker 27) first demonstrated that laminin, an extracellular matrix component, decreases in the corticomedullary junction showing severe tubular necrosis and desquamation by I/R treatment. Walker and colleagues 28) subsequently showed that meprin was the laminin-degrading enzyme. Studies of inbred strains of mice subjected to I/R have revealed that mice expressing low levels of meprin a exhibit markedly less renal damage compared to those that express high levels of this subunit. 18) Carmago et al. 19) have demonstrated that actinonin, a meprin inhibitor, can protect against I/R-induced renal dysfunction in male rats as determined by BUN and Pcr and that this inhibitor provides marked protection against not only hypoxia/reoxygenationbut also hypoxia-induced cell death in renal slices of male rats as determined by lactate dehydrogenase release. Walker et al. 29) have reported that in immunofluorescence experiments, there is a marked increase in meprin in the brush border of male rat kidneys at the end of the ischemia period of 45-min. Taken together with our results, it seems that the initial up-regulation of meprin a subunit in male rat kidneys occurs during the ischemia and is sustained at least until 2 h after reperfusion. The increased meprin a is probably associated with I/R-induced renal injury.
The above findings led us to compare the effect of actinonin on I/R-induced renal injury between male and female rats. We found that pre-ischemic treatment with actinonin prevented the I/R-induced renal dysfunction in males, as previously indicated by Carmago et al. 19) In contrast, actinonin was not capable of suppressing the renal dysfunction in the case of females, in which the degree of the I/R-induced renal injury was much less compared with that in males. Thus, it seems that meprin a is involved in aggravation of I/Rinduced renal injury in male rats.
In the present study, our proteomic analysis showed a sex difference in the protein expression of meprin a subunit after renal I/R. Although it remains unclear what mechanisms are responsible for the sex-dependent alteration in meprin a expression, two studies have reported sex differences in meprin in normal animals: there are differences in the glycosylation of meprin in adult male and female mouse kidneys, and 17b-estradiol affects the posttranslational modification of meprin 30) ; female mice excrete a slightly larger form of meprin in urine, and its proteolytic activity is about 50% of that excreted by male mice. 31) These findings suggest that there are sex differences in post-translational modifications and protein activity of meprin in the kidney and urine. Thus, further studies should determine whether post-translational processing of meprin following renal I/R would differ between male and female rats, and whether sex hormones would affect the expression, glycosylation and activity of meprin in post-ischemic kidneys.
In summary, our results provide information on differences in protein expression at an early phase after reperfusion between male and female rats. Among proteins identified by proteomic analysis, we found that meprin a was significantly up-regulated in the post-ischemic kidney of male rats and that a meprin a inhibitor, actinonin prevented the I/Rinduced renal dysfunction in male but not in female rats. Thus, up-regulation of meprin a is at least partly involved in aggravation of I/R-induced renal injury in male rats. The possibility that meprin a is a key component of the sex difference in ischemic ARF, warrants further attention. However, it cannot be ruled out that except for meprin a, many other proteins which are significantly altered in I/R-treated male or female rat kidneys may also be associated with the sex difference in ischemic ARF.
